Gaofeng Shi1, Qi Wang1, Hui Feng1, Hui Liu1, Mengyu Song1, Xinyue Liang2, and Yongming Dai2
1Department of Radiology, Fourth Hospital of Hebei Medical University, Shijiazhuang, China, 2Central Research Institute, United Imaging Healthcare, Shanghai, China
Synopsis
Keywords: Cancer, Lung
As a promising approach to analyze tumor heterogeneity through image
features, habitat analysis has been applied for a variety of tumors, such as
lung adenocarcinoma (LUAD). To our knowledge, the previous applications, mainly
based on CT and PET images, would potentially hold a limited impact on the
power of habitats analysis. In this study, our goal is to extend the
applications of habitat analysis in LUAD with multi-parametric MR images,
which would be obtained routinely longitudinally and to guide specific
therapies.
Introduction
LUAD is the most common type in non–small cell lung cancer (NSCLC) with a 5-year survival rate lower than 20%.1 World Health Organization (WHO) reported that most LUAD has a mixed-subtype, and the degree of the histopathologic diversity within the tumor is highly associated with patient prognosis. Mounting evidence demonstrated that various subtypes are largely held to be responsible for the aggressive progression and inferior responses to anticancer therapies.2, 3 Therefore, accurate histological subtype classification is vital for therapeutic decision-making.4.5 Biopsy is the gold standard for the classification, but the limited area was unable to represent the entire tumor. To date, a novel method named habitat analysis has been proposed to evaluate the tumor physiology information and its changes with growth or the response to therapy in real-time and long-term. For lung cancer, most studies using habitat analysis were developed based on CT and PET, of which the radiation exposure is still a concern. As such, the noninvasive multi-parametric MRI is a better choice for habitat analysis, not only for its radiation free property but for the functional information it could provide. The aim of the study is to investigate the clinical feasibility of tumor habitat analysis based on multi-parametric MRI in differentiating predominant subtypes of LUAD.Methods
Patients
with confirmed LUAD were evaluated on 3T MR scanner (uMR780, United Imaging
Healthcare, Shanghai, China) using intravoxel incoherent motion
diffusion-weighted imaging (IVIM-DWI) (b = 0, 10, 20, 30, 50, 80, 100, 200, 400
and 800 s/mm2) and oxygen-enhanced MRI with ultrashort echo time
(OE-UTE). The quantitative parameters from IVIM (D, D* and f) were calculated
using a post-processing workstation (United Imaging Healthcare, Shanghai,
China). The voxel-wise percent signal enhancement (PSE) map from OE-MRI of each
patient was obtained with the previous algorithm.6 Primary tumor volumes of interest (VOIs) were labeled by a radiologist
with 10-years’ experience and reviewed by a senior radiologist with 20-years’ experience. K-means
clustering algorithm in Scikit-Learn Python package was used for classifying
different tumor habitats based on D maps and PSE maps. Then, three intratumor habitats
were identified: the necrosis area with high D value and low PSE habitat, the
hypoxia tumor subregion with low D value and low PSE, and the normoxia tumor
subregion with high PSE, respectively. Subsequently, several quantitative parameters
including tumor volume and volume fraction were
calculated on each patient’s corresponding tumor subregions. Habitats parameters were
expressed as mean value with standard deviation (SD). Kruskal-Wallis One-Way ANOVA
test was performed to compare the fraction of each cluster among the three
subtypes. The classification performance was evaluated using the area under the
receiver operating characteristic curve (AUC). Results
A
total of thirty-three patients were recruited in this study. The number of
highly differentiated (adenocarcinoma in situ, minimally invasive
adenocarcinoma or lepidic predominant adenocarcinoma), moderately
differentiated (papillary or acinar predominant adenocarcinoma) and poorly
differentiated (micropapillary, or solid predominant adenocarcinoma) subtypes
was 12, 12, and 9, respectively. Figure 1 showed the workflow and examples of
clustering maps. A relatively large difference in the hypoxia habitat between
three subtypes was observed, which indicated successful discrimination. The distributions
of volume fraction for each habitat were presented in Figure 2. The poorly
differentiated group had a higher volume fraction in hypoxia habitat than the
moderately and highly differentiated groups (P < 0.05). Moreover, the diagnostic model using the volume
fraction of hypoxia habitat (AUC = 0.796) yielded better discriminatory ability
for differentiating tumor subtypes of LUAD than the necrosis habitat (AUC = 0.611) and
normoxia tumor habitat (AUC = 0.694), figure 3.Discussion
In this study, an unsupervised data-driven clustering
method based on D and PSE maps derived from multi-parametric MRI was proposed
to split the tumor volume into three functional habitats. The volume fraction in hypoxia habitat provided independent
prognostic value beyond this in other habitats to stratify patients into
different subtypes. Compared to CT and PET, MRI allows a multidimensional in vivo
characterization of lung cancer, including structural, physiologic, and
functional information without the risk of radiation exposure. The habitat
analysis based on multi-parametric MRI in lung cancer has been firstly
evaluated. Additionally,
hypoxia is the key determinant of tumor subregions towards aggressiveness,
resistance to therapy and poor patient outcomes.7 Higher percentages of hypoxic tumor regions were predictive of
metastasis development in patients, which is in lines with the results of this
study.
This study has several limitations. The main
limitation was the limited number of patients. Besides, a particular protocol
for OE-MRI and IVIM imaging was used in this study which is not universal in
clinical practice.Conclusion
In
conclusion, the volume fraction of hypoxia habitat based on multi-parametric
MRI could be a promising parameter in LUAD histological subtypes
classification.Acknowledgements
None.References
1.Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2020. CA Cancer J Clin 70, 7-30, doi:10.3322/caac.21590 (2020).
2.Dagogo-Jack, I. & Shaw, A. T. Tumour heterogeneity and resistance to cancer therapies. Nature Reviews Clinical Oncology 15, 81-94, doi:10.1038/nrclinonc.2017.166 (2017).
3.Vitale, I., Shema, E., Loi, S. & Galluzzi, L. Intratumoral heterogeneity in cancer progression and response to immunotherapy. Nat Med 27, 212-224, doi:10.1038/s41591-021-01233-9 (2021).
4.Travis, W. D. et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 6, 244-285, doi:10.1097/JTO.0b013e318206a221 (2011).
5.Warth, A. et al. The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival. J Clin Oncol 30, 1438-1446, doi:10.1200/JCO.2011.37.2185 (2012).
6.Liu, H. et al. Pulmonary Functional Imaging for Lung Adenocarcinoma: Combined MRI Assessment Based on IVIM-DWI and OE-UTE-MRI. Front Oncol 11, 677942, doi:10.3389/fonc.2021.677942 (2021).
7.Freeman, S. J. et al. The revised FIGO staging system for uterine malignancies: implications for MR imaging. Radiographics 32, 1805-1827, doi:10.1148/rg.326125519 (2012).